CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals, a clinical stage biopharmaceutical company, today announced the appointment of Dr. Sophie Kornowski as Chair of its Board of Directors and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, today announced additional ...

The positions in the table below reflect the Boston Pharmaceuticals's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and Boston Pharmaceuticals today announced that the companies have entered into an exclusive product license agreement to develop PRS-342, a 4-1BB/GPC3 ...

Ranked by Amount of SBA loan(s) funded or approved in Q2 2025 Boston, MA — November 2025 — Mass Mentoring Partnership (MMP) proudly celebrated its annual Cheers! to Mentoring… Boston, MA, December 1, ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes in a midphase trial, positioning the biotech to advance the ex-Novartis ...

BOSTON, MA / ACCESSWIRE / August 17, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company focused on novel biotherapeutics through its proprietary Anticalin ® ...

Parthenon partnership positions Embark for scale and continued market expansion Embark, a leading management and… Boston, MA – [September 8, 2025] – Brick Marketing, a leading full-service B2B digital ...